{"id":463771,"date":"2020-12-15T16:05:06","date_gmt":"2020-12-15T09:05:06","guid":{"rendered":"https:\/\/www.vibiznews.com\/?p=463771"},"modified":"2020-12-15T16:05:06","modified_gmt":"2020-12-15T09:05:06","slug":"emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk","status":"publish","type":"post","link":"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/","title":{"rendered":"Emiten Baru Pertama Di Tahun 2021, PT Diagnos Laboratorium Utama Tbk"},"content":{"rendered":"<p style=\"text-align: justify;\">(Vibiznews &#8211; IDX Stocks) &#8211; Perusahaan dalam bidang pelayanan penunjang kesehatan, PT Diagnos Laboratorium Utama Tbk, berencana melantai di Bursa Efek Indonesia (BEI) awal tahun 2021.<\/p>\n<p style=\"text-align: justify;\">Dalam prospektus awal yang diterbitkan Senin (14\/12), Diagnos Laboratorium menawarkan sebanyak-banyaknya 250 juta saham dengan nilai nominal Rp 25. Jumlah itu setara 20% dari modal ditempatkan dan disetor perusahaan setelah penawaran umum perdana saham. Perusahaan ini belum mengumumkan harga penawaran tiap sahamnya.<\/p>\n<p style=\"text-align: justify;\">Untuk saat ini, Diagnos Laboratorium masih dalam masa penawaran awal, pada 14-21 Desember 2020. Jika berjalan sesuai rencana, maka pada 29 Desember 2020 Diagnos Laboratorium akan memasuki tanggal efektif. Kemudian pada 4-8 Januari 2021 memasuki masa penawaran umum perdana saham.<\/p>\n<p style=\"text-align: justify;\">Dilanjutkan pada 12 Januari 2021 yang akan dilakukan penjatahan. Lalu pada 14 Januari 2021 akan dilakukan pengembalian uang pemesanan, sekaligus distribusi saham secara elektronik. Sehingga, pada 15 Januari 2021 diharapkan Diagnos Laboratorium Utama bisa secara resmi mencatatkan sahamnya di BEI.<\/p>\n<p style=\"text-align: justify;\"><span style=\"text-align: justify;\">Mengutip prospektus awal, sebesar 42,6% dari dana yang dihimpun nanti akan dimanfaatkan untuk pengembangan usaha. Sementara itu, 57,4% dana sisanya akan dimanfaatkan untuk modal kerja perusahaan.\u00a0<\/span><\/p>\n<p style=\"text-align: justify;\">Rincian pengembangan usaha antara lain\u00a0pembelian peralatan memerlukan dana sekitar Rp 8,35 miliar dan pembelian kendaraan memerlukan dana sekitar Rp 4,95 milliar. Adapun jumlah kendaraan yang akan dibeli sekitar 18 unit kendaraan roda empat.<\/p>\n<p style=\"text-align: justify;\">Selain itu, dana akan digunakan untuk pembangunan laboratorium hingga Rp 8 miliar. Untuk diketahui, PT. Diagnos Laboratorium Utama Tbk memiliki rencana membangun laboratorium utama, pembangunan cabang Makassar, pembangunan cabang Surabaya, dan pembangunan cabang Medan yang ditargetkan akan selesai pada tahun 2021.<\/p>\n<p style=\"text-align: justify;\">Dalam melakukan proses penawaran umum perdana saham, Diagnos Laboratorium Utama menggandeng PT Mirae Asset Sekuritas Indonesia sebagai pelaksana emisi efek. Untuk penjamin emisi efeknya akan ditentukan kemudian.<\/p>\n<p><em>Selasti Panjaitan\/Vibiznews<\/em><br \/>\n<em>Editor : Asido Situmorang<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Vibiznews &#8211; IDX Stocks) &#8211; Perusahaan dalam bidang pelayanan penunjang kesehatan, PT Diagnos Laboratorium Utama Tbk, berencana melantai di Bursa Efek Indonesia (BEI) awal tahun 2021. Dalam prospektus awal yang diterbitkan Senin (14\/12), Diagnos Laboratorium menawarkan sebanyak-banyaknya 250 juta saham dengan nilai nominal Rp 25. Jumlah itu setara 20% dari modal ditempatkan dan disetor perusahaan [&hellip;]<\/p>\n","protected":false},"author":15,"featured_media":463775,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[19],"tags":[],"class_list":["post-463771","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-idx-stock"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Emiten Baru Pertama Di Tahun 2021, PT Diagnos Laboratorium Utama Tbk - Vibiznews.com<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Emiten Baru Pertama Di Tahun 2021, PT Diagnos Laboratorium Utama Tbk - Vibiznews.com\" \/>\n<meta property=\"og:description\" content=\"(Vibiznews &#8211; IDX Stocks) &#8211; Perusahaan dalam bidang pelayanan penunjang kesehatan, PT Diagnos Laboratorium Utama Tbk, berencana melantai di Bursa Efek Indonesia (BEI) awal tahun 2021. Dalam prospektus awal yang diterbitkan Senin (14\/12), Diagnos Laboratorium menawarkan sebanyak-banyaknya 250 juta saham dengan nilai nominal Rp 25. Jumlah itu setara 20% dari modal ditempatkan dan disetor perusahaan [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/\" \/>\n<meta property=\"og:site_name\" content=\"Vibiznews.com\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-15T09:05:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/12\/bei-diagnos-lab.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1440\" \/>\n\t<meta property=\"og:image:height\" content=\"868\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Selasti Panjaitan\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Selasti Panjaitan\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/\",\"url\":\"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/\",\"name\":\"Emiten Baru Pertama Di Tahun 2021, PT Diagnos Laboratorium Utama Tbk - Vibiznews.com\",\"isPartOf\":{\"@id\":\"https:\/\/vibiznews.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/12\/bei-diagnos-lab.jpg\",\"datePublished\":\"2020-12-15T09:05:06+00:00\",\"dateModified\":\"2020-12-15T09:05:06+00:00\",\"author\":{\"@id\":\"https:\/\/vibiznews.com\/#\/schema\/person\/039dae6f7037862e0ab65f0ff97b7981\"},\"breadcrumb\":{\"@id\":\"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/#primaryimage\",\"url\":\"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/12\/bei-diagnos-lab.jpg\",\"contentUrl\":\"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/12\/bei-diagnos-lab.jpg\",\"width\":1440,\"height\":868},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/vibiznews.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Emiten Baru Pertama Di Tahun 2021, PT Diagnos Laboratorium Utama Tbk\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/vibiznews.com\/#website\",\"url\":\"https:\/\/vibiznews.com\/\",\"name\":\"Vibiznews.com\",\"description\":\"Berita Bisnis | Berita Komoditi | Berita Saham\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/vibiznews.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/vibiznews.com\/#\/schema\/person\/039dae6f7037862e0ab65f0ff97b7981\",\"name\":\"Selasti Panjaitan\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/vibiznews.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/077618055791b3905656b044fd0a2f4f?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/077618055791b3905656b044fd0a2f4f?s=96&d=mm&r=g\",\"caption\":\"Selasti Panjaitan\"},\"description\":\"Selasti Panjaitan is a Senior Equity Research of Vibiz Research Center and also as Partner of Wealth Planning Services at Vibiz Consulting\",\"sameAs\":[\"http:\/\/www.vibiznews.com\"],\"url\":\"https:\/\/vibiznews.com\/index.php\/author\/selasti-panjaitan\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Emiten Baru Pertama Di Tahun 2021, PT Diagnos Laboratorium Utama Tbk - Vibiznews.com","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/","og_locale":"en_US","og_type":"article","og_title":"Emiten Baru Pertama Di Tahun 2021, PT Diagnos Laboratorium Utama Tbk - Vibiznews.com","og_description":"(Vibiznews &#8211; IDX Stocks) &#8211; Perusahaan dalam bidang pelayanan penunjang kesehatan, PT Diagnos Laboratorium Utama Tbk, berencana melantai di Bursa Efek Indonesia (BEI) awal tahun 2021. Dalam prospektus awal yang diterbitkan Senin (14\/12), Diagnos Laboratorium menawarkan sebanyak-banyaknya 250 juta saham dengan nilai nominal Rp 25. Jumlah itu setara 20% dari modal ditempatkan dan disetor perusahaan [&hellip;]","og_url":"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/","og_site_name":"Vibiznews.com","article_published_time":"2020-12-15T09:05:06+00:00","og_image":[{"width":1440,"height":868,"url":"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/12\/bei-diagnos-lab.jpg","type":"image\/jpeg"}],"author":"Selasti Panjaitan","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Selasti Panjaitan","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/","url":"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/","name":"Emiten Baru Pertama Di Tahun 2021, PT Diagnos Laboratorium Utama Tbk - Vibiznews.com","isPartOf":{"@id":"https:\/\/vibiznews.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/#primaryimage"},"image":{"@id":"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/#primaryimage"},"thumbnailUrl":"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/12\/bei-diagnos-lab.jpg","datePublished":"2020-12-15T09:05:06+00:00","dateModified":"2020-12-15T09:05:06+00:00","author":{"@id":"https:\/\/vibiznews.com\/#\/schema\/person\/039dae6f7037862e0ab65f0ff97b7981"},"breadcrumb":{"@id":"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/#primaryimage","url":"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/12\/bei-diagnos-lab.jpg","contentUrl":"https:\/\/vibiznews.com\/wp-content\/uploads\/2020\/12\/bei-diagnos-lab.jpg","width":1440,"height":868},{"@type":"BreadcrumbList","@id":"https:\/\/vibiznews.com\/index.php\/2020\/12\/15\/emiten-baru-pertama-di-tahun-2021-pt-diagnos-laboratorium-utama-tbk\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vibiznews.com\/"},{"@type":"ListItem","position":2,"name":"Emiten Baru Pertama Di Tahun 2021, PT Diagnos Laboratorium Utama Tbk"}]},{"@type":"WebSite","@id":"https:\/\/vibiznews.com\/#website","url":"https:\/\/vibiznews.com\/","name":"Vibiznews.com","description":"Berita Bisnis | Berita Komoditi | Berita Saham","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vibiznews.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/vibiznews.com\/#\/schema\/person\/039dae6f7037862e0ab65f0ff97b7981","name":"Selasti Panjaitan","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vibiznews.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/077618055791b3905656b044fd0a2f4f?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/077618055791b3905656b044fd0a2f4f?s=96&d=mm&r=g","caption":"Selasti Panjaitan"},"description":"Selasti Panjaitan is a Senior Equity Research of Vibiz Research Center and also as Partner of Wealth Planning Services at Vibiz Consulting","sameAs":["http:\/\/www.vibiznews.com"],"url":"https:\/\/vibiznews.com\/index.php\/author\/selasti-panjaitan\/"}]}},"_links":{"self":[{"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/posts\/463771","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/comments?post=463771"}],"version-history":[{"count":1,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/posts\/463771\/revisions"}],"predecessor-version":[{"id":463777,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/posts\/463771\/revisions\/463777"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/media\/463775"}],"wp:attachment":[{"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/media?parent=463771"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/categories?post=463771"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vibiznews.com\/index.php\/wp-json\/wp\/v2\/tags?post=463771"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}